CYTK Insider Trading Activity and SEC Form 4 Filings
CYTK insider trading summary
Over the past 12 months, insiders at Cytokinetics Inc (CYTK) reported 75 sales worth $47.1M by 10 insiders and no open-market purchases on SEC Form 4. Net insider selling was $47.1M.
Latest CYTK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Fady Ibraham Malik | EVP Research & Development | Sell | $220K (3,500 @ $62.93) |
| Nov 2, 2026 | Robert I Blum | President & CEO | Sell | $471K (7,500 @ $62.81) |
| Oct 20, 2026 | Fady Ibraham Malik | EVP Research & Development | Sell | $224K (3,500 @ $64.01) |
| Oct 12, 2026 | Robert I Blum | President & CEO | Sell | $472K (7,500 @ $62.88) |
| Oct 6, 2026 | Fady Ibraham Malik | EVP Research & Development | Sell | $215K (3,500 @ $61.38) |
| Sep 28, 2026 | Robert I Blum | President & CEO | Sell | $491K (7,500 @ $65.46) |
| Sep 22, 2026 | Fady Ibraham Malik | EVP Research & Development | Sell | $239K (3,500 @ $68.29) |
| Sep 15, 2026 | Robert E Landry | Director | Sell | $72K (1,000 @ $72.13) |
| Sep 15, 2026 | Robert I Blum | President & CEO | Sell | $6.8M (97,926 @ $69.33) |
| Sep 14, 2026 | Robert I Blum | President & CEO | Sell | $551K (7,500 @ $73.44) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.